To visit the old Ventura website, click here.
Ventura Wealth Clients Login here
Refer and earnSupport
logosearch
Create Account
hamburger
home
breadcrumbStocks
breadcrumbEris Lifesciences Ltd Share Price

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open1,770.1
High1,795
Low1,756.4
Prev. Close1,775.7
Avg. Traded Price1,771.55
Volume53,136

MARKET DEPTH

info2
Total bid7.00
Total ask0.00
OrdersQtyBid
171775.7
000
000
000
000
AskQtyOrders
000
000
000
000
000

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

₹1,756.408 hours ago
₹1,795.002 hours ago
arrow

LOWER/UPPER CIRCUITS

₹1,414.90
₹2,122.30
arrow
Eris Lifesciences Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Revenue,rose 43.24%, in the last year to ₹2,912 Cr. Its sector's average revenue growth for the last fiscal year was 10.77%.
noteQuarterly Revenue,rose 28.02% YoY to ₹713.25 Cr. Its sector's average revenue growth YoY for the quarter was 11.41%.
noteQuarterly Net profit,rose 32.24% YoY to ₹93.84 Cr. Its sector's average net profit growth YoY for the quarter was 37.87%.
View more

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : 5.51%
Net profit growth 5Y CAGR : 6.4%

Similar stocks

Eris Lifesciences Limited founded by Amit Bakshi and team in 2007 is one of the fastest growing companies within the chronic and acute categories of the Indian Branded Formulations market such as: cardiovascular; anti–diabetes; vitamins; gastroenterology and gynaecology. The company develops, manufactures and commercializes branded pharmaceutical products in select therapeutic areas within the chronic and acute categories of the IPM, such as: cardiovascular; anti-diabetics; vitamins; gastroenterology; and anti-infectives. Its focus has been on developing products in the chronic and acute category which are linked to lifestyle related disorders.
personal

Grow your wealth with more research recommendations

+91